Penetrating topical pharmaceutical compositions containing N-(2-

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514171, 514549, 514300, 514826, 514825, 514859, A01N 4336, A61K 3140

Patent

active

045377766

ABSTRACT:
Topical pharmaceutical compositions comprising a pharmaceutically-active agent and a novel, penetration-enhancing vehicle or carrier are disclosed. The vehicle or carrier comprises a binary combination of N-(2-Hydroxyethyl) pyrrolidone and a "cell-envelope disordering compound". The compositions provide marked transepidermal and percutaneous delivery of the active selected. A method of treating certain pathologies and conditions responsive to the selected active, systemically or locally, is also disclosed.

REFERENCES:
patent: 2990331 (1961-06-01), Neumann et al.
patent: 3535422 (1970-10-01), Cox et al.
patent: 3934013 (1976-01-01), Poulsen
patent: 3989816 (1976-11-01), Rhaadhyaksha
patent: 4006218 (1977-02-01), Sipos
patent: 4017641 (1977-04-01), DiGiulio
patent: 4070462 (1978-02-01), Ecker
patent: 4075353 (1978-02-01), Mandy
patent: 4126681 (1978-11-01), Reller
patent: 4132781 (1984-09-01), Stoughton
patent: 4289764 (1981-09-01), Yarrow
patent: 4299826 (1981-11-01), Luedders
patent: 4343798 (1982-08-01), Fawzi
patent: 4423040 (1983-12-01), Rajadbyaksha
Chemical Abstracts, vol. 100 (1984), Par. 174,945k.
Stoughton, "Enhanced Percutaneous Penetration with 1-Dodecylazacycloheptan-2-One", Arch. Derm., 118, pp. 474-477, (1982).
Rosuold, J., et al., "Effect of Formulation on In Vitro Release and In Vivo Absorption of Corticosteroids from Ointments", Medd. Novsk Favm Selsk, 44, 21-45, (1982).
Anjo, D. M., et al., "Methods for Predicting Percutaneous Penetration in Man", Percutaneous Absorption of Steroids, pp. 31-51, Academic Press NY, NY, (1980).
CA 92:153,181j.
H. Barnes et al., Br. J. Derm., 93, 459, (1975).
P. J. W. Ayres et al., Br. J. Derm., 99, 307, (1978).
Schaaf and Gross, Dermatologica, 106, 357, (1953).
J. Zatz et al., J. Pharm. Sci., 67, 789, (1978).
S. K. Chandrasekaran et al., J. Pharm. Sci., 67, 1370, (1978).
B. Idson, Cosmetics & Toiletries, 95, 59, (1980).
M. M. Rieger, Cosmetics & Toiletries, 94, 32-37, (1979), and 95, 26-38, (1980).
CA 79: 122,308.
U.S. patent application Ser. No. 1,974, 1/8/79, Wickett et al.
U.S. patent application Ser. No. 383,391, 6/1/82, Cooper.
U.S. patent application Ser. No. 506,275, 6/21/83, Cooper.
U.S. patent application Ser. No. 506,274, 6/21/83, Cooper et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Penetrating topical pharmaceutical compositions containing N-(2- does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Penetrating topical pharmaceutical compositions containing N-(2-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Penetrating topical pharmaceutical compositions containing N-(2- will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2001239

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.